Esposito M, Grusovin M G, Worthington H V, Coulthard P
School of Dentistry, University of Manchester, Oral and Maxillofacial Surgery, Higher Cambridge Street, Manchester, UK, M15 6FH.
Cochrane Database Syst Rev. 2006 Jan 25(1):CD003607. doi: 10.1002/14651858.CD003607.pub2.
Dental implants require sufficient bone to be adequately stabilised. For some patients implant treatment would not be an option without bone augmentation. A variety of materials and surgical techniques are available for bone augmentation.
General objectives: To test the null hypothesis of no difference in the success, function, morbidity and patient satisfaction between different bone augmentation techniques for dental implant treatment.
(A) to test whether and when augmentation procedures are necessary; (B) to test which is the most effective augmentation technique for specific clinical indications. Trials were divided into three broad categories according to different indications for the bone augmentation techniques: (1) major vertical or horizontal bone augmentation or both; (2) implants placed in extraction sockets; (3) fenestrated implants.
The Cochrane Oral Health Group's Trials Register, the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE and EMBASE were searched. Several dental journals were handsearched. The bibliographies of review articles were checked, and personal references were searched. More than 55 implant manufacturing companies were also contacted. Last electronic search was conducted on 1 October 2005.
Randomised controlled trials (RCTs) of different techniques and materials for augmenting bone for implant treatment reporting the outcome of implant therapy at least to abutment connection.
Screening of eligible studies, assessment of the methodological quality of the trials and data extraction were conducted independently and in duplicate. Authors were contacted for any missing information. Results were expressed as random-effects models using weighted mean differences for continuous outcomes and odd ratios for dichotomous outcomes with 95% confidence intervals. The statistical unit of the analysis was the patient.
Thirteen RCTs out of 29 potentially eligible trials reporting the outcome of 330 patients were suitable for inclusion. Since different techniques were evaluated in different trials, no meta-analysis could be performed. Six trials evaluated different techniques for vertical or horizontal bone augmentation or both. Four trials evaluated different techniques of bone grafting for implants placed in extraction sockets and three trials evaluated different techniques to treat bone dehiscence or fenestrations around implants.
AUTHORS' CONCLUSIONS: Major bone grafting procedures of extremely resorbed mandibles may not be justified. Bone substitutes (Bio-Oss or Cerasorb) may replace autogenous bone for sinus lift procedures of extremely atrophic sinuses. Both guided bone regeneration (GBR) procedures and distraction osteogenesis can augment bone vertically, but it is unclear which is the most efficient technique. It is unclear whether augmentation procedures at immediate single implants placed in fresh extraction sockets are needed, and which is the most effective augmentation procedure, however, sites treated with barrier + Bio-Oss showed a higher position of the gingival margin, when compared to sites treated with barriers alone. Non-resorbable barriers at fenestrated implants regenerated more bone than no barriers, however it remains unclear whether such bone is of benefit to the patient. It is unclear which is the most effective technique for augmenting bone around fenestrated implants. No bone promoting molecule has been shown to be effective or necessary in conjunction with dental implant treatment. The use of particulated autogenous bone from intraoral locations, also taken with dedicated aspirators, might be associated with an increased risk of infective complications. These findings are based on few trials including few patients, having sometimes short follow up, and being often judged to be at high risk of bias.
牙种植体需要足够的骨组织来实现充分稳定。对于一些患者而言,若不进行骨增量,种植治疗将无法实施。目前有多种材料和手术技术可用于骨增量。
总体目标:检验不同骨增量技术用于牙种植治疗时,在成功率、功能、发病率及患者满意度方面无差异这一无效假设。
(A)检验骨增量程序是否必要以及何时必要;(B)检验针对特定临床指征哪种骨增量技术最有效。根据骨增量技术的不同指征,试验分为三大类:(1)主要的垂直或水平骨增量或两者兼具;(2)种植体植入拔牙窝;(3)有骨开窗的种植体。
检索了Cochrane口腔健康组试验注册库、Cochrane对照试验中央注册库(CENTRAL)、MEDLINE和EMBASE。对几本牙科杂志进行了手工检索。检查了综述文章的参考文献,并检索了个人参考文献。还联系了55多家种植体制造公司。最后一次电子检索于2005年10月1日进行。
不同技术和材料用于种植治疗骨增量的随机对照试验(RCT),报告种植治疗至少至基台连接阶段的结果。
对符合条件的研究进行筛选、对试验的方法学质量进行评估以及数据提取均独立进行且重复操作。就任何缺失信息与作者进行了联系。结果以随机效应模型表示,连续结局采用加权均数差,二分结局采用比值比,并给出95%置信区间。分析的统计单位是患者。
29项可能符合条件的试验中有13项RCT报告了330例患者的结果,这些试验适合纳入。由于不同试验评估的技术不同,因此无法进行荟萃分析。6项试验评估了垂直或水平骨增量或两者兼具的不同技术。4项试验评估了种植体植入拔牙窝时不同的骨移植技术,3项试验评估了治疗种植体周围骨开窗或骨缺损的不同技术。
极重度吸收的下颌骨进行主要的骨移植手术可能不合理。骨替代材料(Bio - Oss或Cerasorb)可在极萎缩上颌窦提升术中替代自体骨。引导骨再生(GBR)程序和牵张成骨均可垂直增加骨量,但尚不清楚哪种技术效率最高。对于即刻植入新鲜拔牙窝的单颗种植体是否需要进行骨增量程序以及哪种骨增量程序最有效尚不清楚,然而,与仅使用屏障膜处理的部位相比,使用屏障膜 + Bio - Oss处理的部位牙龈边缘位置更高。有骨开窗的种植体使用不可吸收屏障膜比不使用屏障膜能再生更多骨,但尚不清楚这种骨对患者是否有益。尚不清楚哪种技术对有骨开窗的种植体周围骨增量最有效。没有证据表明骨促进分子与牙种植治疗联合使用是有效或必要的。使用口腔内部位的自体碎骨,即便使用专用吸引器,也可能增加感染并发症的风险。这些发现基于少数试验,纳入患者数量较少,随访时间有时较短,且常被判定存在较高偏倚风险。